News

TASE Achieves Significant Revenue and Profit Growth in 2024

TASE Achieves Significant Revenue and Profit Growth in 2024

Record Financial Performance by TASE

In a remarkable achievement, TASE has reported impressive financial results for the year, showcasing a 12% increase in revenue, bringing total revenues to NIS 438 million. This is complemented by a substantial 22% rise in net profit, amounting to NIS 101 million.

Impressive Adjusted EBITDA

The adjusted EBITDA demonstrated robust growth, reaching 42.6% of revenues, totaling NIS 186 million, up from NIS 158 million recorded in the previous year. This 18% increase highlights TASE's operational efficiency and successful cost management strategies.

Dividend Distribution to Shareholders

In alignment with its strong performance, TASE has announced a significant dividend distribution of NIS 51 million, which represents 50% of the annual net profit for 2024. This decision underscores the company's commitment to delivering value to its shareholders.

Comprehensive Capital Returns

From January 2024 to March 2025, TASE projects total capital returns to shareholders to reach NIS 526 million. This includes dividends and share buybacks, showcasing TASE's proactive approach to providing returns amidst market challenges.

Trading Performance and Market Resilience

Despite operating in a tumultuous environment characterized by ongoing geopolitical tensions, TASE has demonstrated notable resilience. The leading TASE equity indices outperformed global counterparts, with the TA-125 index surging 29%, while the TA-35 index rose 28%. This performance reflects investor confidence and the TASE's strategic positioning in the global market.

Notable Trading Volume Increases

The trading volumes on TASE increased significantly throughout the year, with an average daily trading volume reaching NIS 2.2 billion, a 10% increase from the previous year. This growth reflects heightened investor participation and engagement in the market.

New Listings and IPOs

In 2024, TASE welcomed eight new companies that completed IPOs with an aggregate value of NIS 8.4 billion. This trend of new listings indicates a vibrant market appeal and TASE's role as a favorable platform for capital raising.

Strength in the Bonds Market

The bonds market also experienced significant growth in 2024, with corporate bond issuances totaling NIS 123.5 billion. This marks an increase from NIS 100 billion in 2023, reinforcing TASE's position as a key venue for debt financing in Israel.

Core Activities and Strategic Initiatives

Throughout 2024, TASE continued to build on its core activities by investing in market infrastructure and technology. In collaboration with the Israel Securities Authority and the Bank of Israel, TASE announced plans to shift its trading week to align with international standards, enhancing market accessibility for foreign investors.

AI Initiatives for Enhanced Reporting

TASE has also initiated the use of artificial intelligence to translate immediate reports into English, improving accessibility for international investors. This effort demonstrates TASE's forward-thinking approach to expanding its global reach.

Enhancements in Trading Capacity

Responding to increased trading demand, TASE expanded its colocation capacity significantly in the last quarter of 2024. This includes establishing new points of presence internationally, facilitating better connectivity and trading capabilities for clients.

Future Outlook and Commitment

Looking ahead, TASE remains committed to advancing its market position through innovation, strategic partnerships, and a focus on enhancing the trading experience for both existing and new investors. TASE’s proactive approach in developing new product offerings and enhancing operational efficiency positions it well for sustained growth.

Frequently Asked Questions

What were the main highlights of TASE's 2024 financial performance?

TASE achieved a record revenue of NIS 438 million and a net profit of NIS 101 million in 2024.

How much dividend did TASE declare for its shareholders?

TASE declared a dividend of NIS 51 million, representing 50% of its net profit for the year.

What was the impact of the market conditions on TASE's performance?

Despite geopolitical challenges, TASE's indices outperformed global benchmarks, illustrating market resilience.

How did the trading volume change in 2024?

The average daily trading volume increased to NIS 2.2 billion, reflecting greater investor engagement.

What strategic initiatives is TASE pursuing for future growth?

TASE plans to implement trading week changes and leverage AI for enhanced accessibility, positioning itself for further growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 211

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 0

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 249

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 139

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading